Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits
-
- Saito Yoshiro
- Systems Life Sciences Laboratory, Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University
-
- Misu Hirofumi
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences PRESTO, Japan Science and Technology Agency
-
- Takayama Hiroaki
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Takashima Shin-ichiro
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Usui Soichiro
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Takamura Masayuki
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Kaneko Shuichi
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
-
- Takamura Toshinari
- Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences
-
- Noguchi Noriko
- Systems Life Sciences Laboratory, Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University
Search this article
Abstract
<p>Selenoprotein P (SeP) is a selenium (Se)-rich extracellular protein. SeP is identified as a hepatokine, causing insulin resistance in type 2 diabetes. Thus, the measurement of SeP in serum has received much attention, and several enzyme-linked immunosorbent assay (ELISA) kits for SeP determination are now commercially available. In the present study, we determined the serum SeP levels by our original ELISA and sol particle homogeneous immunoassay (SPIA) methods and also by commercially available kits, and these determinants were compared. We found a kit-dependent correlation of the determinants with our methods. These results suggest that the selection of kit is critical for comparison with our previous reports and for discussing the relationship between the serum SeP levels and disease condition.</p>
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 41 (5), 828-832, 2018-05-01
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204631265664
-
- NII Article ID
- 130006730702
-
- NII Book ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 028958859
-
- PubMed
- 29709922
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed